Covid-19 Pandemic
 Here’s the latest news from the global pandemic. Moderna reaches $1.5 billion U.S. deal for vaccine dosesCoronavirus return threatens New Zealand’s recovery U.K.’s virus economic slump is worst in Europe Reading the fine print on Russia’s vaccine Long before many experts said it was possible, the world has its first officially sanctioned coronavirus vaccine. Before lining up for a shot, it’s worth reading the fine print. Russia on Tuesday green-lighted a vaccine developed by its own researchers, and President Vladimir Putin said the country hopes to begin mass inoculation soon. With the global Covid-19 death toll climbing to 738,000 and new clusters of infection emerging, that sounds like good news. Vaccines for other diseases have taken years to develop; this one was cooked up in months. The problem is that Russia, in its eagerness to lap the world with a project dubbed Sputnik V, bypassed key parts of the standard drug- and vaccine-development protocol. This new moon shot has been tested on only a handful of people, so we don’t really know whether it works or is safe. Those are big caveats, and could complicate efforts to inoculate the world’s population against the virus when other vaccines under development are rolled out — some of them maybe even before the end of the year. Any problems with the Russian shot will give the resurgent antivax movement a propaganda victory. To be sure, there are questions around other vaccine candidates, too. Moderna Inc., which reached a $1.5 billion deal with the Trump administration this week to supply 100 million doses, is one of several companies pushing a novel technology called mRNA. Its shot produced side effects among participants in clinical trials. Other early vaccines, possibly including one from the University of Oxford and AstraZeneca Plc, may not stop you from catching or spreading the virus though might prevent severe illness or death. That’s a huge step, but still imperfect in the world of vaccines. The Sputnik 1 satellite sent into orbit in 1957 was unmanned. Sputnik V aside, most vaccines under development won’t be launched without large-scale human trials. Success or failure will be plain to see. With the Russian vaccine, we may never know, and that’s a big risk. —Eric Pfanner Track the virus More Than 20 Million Infected Worldwide Nations in Asia are struggling to contain new waves. See the latest infection trends here.  Sponsored Content by Siemens America’s factories, power plants, transportation and hospitals all need technology and our technology is only as powerful as the people deploying and maintaining it. Keeping America moving takes more than technology alone. It takes a human touch. Siemens Ingenuity for life. What you should read India Aims to Make Covid Vaccines Affordable The Serum Institute of India is preparing to crank out a billion doses. The World’s Airports Are Catching Coronavirus After spending billions, a dearth of well-heeled travelers. France’s Covid Response Has Its Je ne Sais Quoi Retaining public trust while enforcing surreal face-mask rules a challenge. Teen Tobacco Use Linked to Higher Covid Risk Young people who smoked and vaped reported higher disease rate. Pandemic Keeps Global Youth on Back Foot Issue is latest example of inequality complicating recovery. Know someone else who would like this newsletter? Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg’s Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022 |
PreviousOhio Covid-19